Literature DB >> 7722803

Mycoses in AIDS patients.

B Dupont1, D W Denning, D Marriott, A Sugar, M A Viviani, T Sirisanthana.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7722803     DOI: 10.1080/02681219480000731

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


× No keyword cloud information.
  7 in total

1.  Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strains.

Authors:  S Nho; M J Anderson; C B Moore; D W Denning
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

2.  First report of drug-induced esophagitis by deferasirox.

Authors:  Takeshi Yoshikawa; Takeshi Hara; Hiroshi Araki; Hisashi Tsurumi; Masami Oyama; Hisataka Moriwaki
Journal:  Int J Hematol       Date:  2012-05-01       Impact factor: 2.490

3.  Oral carriage of Candida albicans in murine AIDS.

Authors:  N Deslauriers; L Côté; S Montplaisir; L de Repentigny
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

4.  Mechanisms of the in vitro fungicidal effects of human neutrophils against Penicillium marneffei induced by granulocyte-macrophage colony-stimulating factor (GM-CSF).

Authors:  N Kudeken; K Kawakami; A Saito
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

5.  Evaluation of a commercial medium for identification of Candida species.

Authors:  R San-Millán; L Ribacoba; J Pontón; G Quindós
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

6.  Different susceptibilities of yeasts and conidia of Penicillium marneffei to nitric oxide (NO)-mediated fungicidal activity of murine macrophages.

Authors:  N Kudeken; K Kawakami; A Saito
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

7.  Role of posaconazole in the management of oropharyngeal and esophageal candidiasis.

Authors:  Jose A Vazquez
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.